2025 second_quarter Filing
Q2Income
$25K
Filed
July 23, 2025
Lobbying Activities
Health IssuesView all
Development of Amicidins to serve as a countermeasure/therapeutic intervention for Sepsis
Contacted:Health & Human Services, Dept of (HHS), HOUSE OF REPRESENTATIVES, SENATE
Lobbyists (1)
DANIEL FARACI